GODAVARI DRUGS LIMITED
Key Event and Approval
The Members of GODAVARI DRUGS LIMITED approved the alteration of the Object Clause of the Memorandum of Association of the Company by way of a Special Resolution at the 38th Annual General Meeting held on 25th September, 2026.
Consequential Change and Registration
Consequent upon the alteration of the Object Clause and reclassification of the company's business activity under the applicable National Industrial Classification (NIC) Code, the Corporate Identification Number (CIN) has been changed. The Ministry of Corporate Affairs registered this alteration on 16th October, 2026, in accordance with Section 13(1) of the Companies Act, 2013.
Specific Details of CIN Change
| Particulars | Details |
| Name of the Company | GODAVARI DRUGS LIMITED |
| Existing CIN | L24230TG1987PLC008016 |
| Revised CIN | L21001TG1987PLC008016 |
| Date of Registration of Alteration of Object Clause | 16th October, 2026 |
Documentation
A copy of the Certificate of Registration issued by the Ministry of Corporate Affairs dated 16th October, 2026 was enclosed with the submission to BSE. The certificate was digitally signed by Ibson Shah, Assistant Registrar of Companies/Deputy Registrar of Companies/Registrar of Companies at the Central Processing Centre.
Purpose of Intimation
The company submitted this intimation to apprise the Stock Exchange of the development and place the updated CIN particulars on record.